To determine the prevalence of non alcoholic fatty liver disease (NAFLD) and non alcoholic steatohepatitis (NASH) in morbidly obese patients undergoing bariatric surgery and to identify risk factors associated with the disease spectrum.
-ORIGINAL ARTICLE CLINICAL INVESTIGATION
The spectrum of non alcoholic fatty liver disease in morbidly obese patients. Several studies have been conducted to evaluate the real prevalence of NASH and NAFLD in severely obese patients that underwent bariatric surgery, when liver biopsy was performed.
The prevalence varied from 27 to 98%, which may be explained by recent modifications in histological classification
It is of great importance to predict and prevent the development of advanced liver diseases in obese patients.
Determining the prevalence of NASH in those patients and further understanding the role of certain predictor factors is of interest, since it would aid in identifying patients at high risk. Furthermore, patients undergoing bariatric surgery would greatly benefit from strategies to allow detection of NASH and closer follow-up
given they are at increased risk for the development of cirrhosis, hepatocellular and end-stage liver disease.
Therefore, the aim of this study was to prospectively determine the prevalence of NASH in obese patients undergoing bariatric surgery from Northeastern of Brazil and to identify risk factors involved in the development of NASH.
Methods
The study was approved by the Ethics Committee for Clinical Investigation at Ceara Federal University of Brazil.
Informed written consent was obtained from every patient. 
Histological evaluation
The material was fixed in paraffin and stained: H&E; Patients were defined as having NAFLD when they had at least steatosis on biopsy, which was graded on a scale of 0 to 3 according to the criteria of Brunt et al.
11
. NASH diagnosis was defined as the presence of at least three of the four initial histological findings: 1) predominant macrovesicular steatosis in zone 3, 2) neutrophilic lobular inflammation 3), hepatocellular ballooning, 4) perisinusoidal fibrosis, according to the criteria of Brunt et al.
. The degree of steatosis was assessed on a scale of 0 to 3.
Zero, indicating no: 1, mild (<33% of parenchyma involved) 2, moderate (33% to 66% of parenchyma involved), and 3, severe (> 66% of parenchyma involved). The degree of lobular inflammation was also graded on a scale of 0 to 3. Zero: no inflammation; .
Statistical analysis
Results are expressed as mean ± SD and percentages.
Comparisons of quantitative variables were made using the with SPSS computer software (version 11.5).
Results
Seventy-eight patients were invited to participate in the study, one was excluded for presenting positive marker for hepatitis C during the evaluation, four decided not to carry out with surgery, two had inadequate biopsy sample and eleven did not undergo biopsy for various technical reasons. A total of 60 patients, (73% female and 27% male) were considered for analysis.
Laboratory and demographic evaluation
Patients (mean age ± SD, 38.4 ± 11.6,) had a mean ± SD BMI of 44.2 kg/m2 ± 5.5, mean ± SD CC 125.8 ± 15.2 cm and mean ± SD of the sample WHR 0.93 ± 0.11. Thirty-four (56.6%) were hypertensive, twenty (33%) were type 2 diabetic or had changes in fasting glucose, thirty-one (51.7%) had altered lipid profile and thirty-nine (65%) fell within the metabolic syndrome. Thirty-eight (63.3%) were abstainers, and only one (1.67%) consumed between 20 -30 g alcohol / day. The liver function tests together (AST, ALT, GGT, total bilirubin and fractions and alkaline phosphatase) were normal in twenty-seven patients (45%). γGT was raised in twentythree (38.3%), ALT in twenty (33.3%), AST in eight (13.33%).
The mean ratio of AST / ALT was 0.76 (range, 0.27 to 1.61), with the ratio AST / ALT> 1 detected in six (10%). Twenty-one (35%)
had slightly elevated levels of ferritin and transferrin saturation index normal in all.
Histological data
Liver biopsy results are summarized in Table 1 
Factors associated with NASH
In the univariable analysis, the factors that were significantly associated with NAFLD were: triglycerides (P = 0.029); group consisting of type 2 diabetes and those with impaired fasting glucose (P = 0.044), fasting glucose greater than 110mg/ dL (p = 0.034), ALT changes (p = 0.044). The logistic regression analysis identified no factor independently associated with NASH.
Factors associated with fibrosis
Zone 3 perisinusoidal fibrosis was detected in three cases (7.5%) while the isolated portal fibrosis was seen in seven (11.6%). Table 3 . 
Discussion
The present prospective study evaluated liver biopsies of patients that underwent bariatric surgery. The prevalence of NAFLD in the sample in this study was 95%, and among patients with NAFLD, twenty-four (42.1%) scored higher (Grade II and III). We found a lower rate of fibrosis in this asymptomatic population (12%) than is commonly identified and no evidence of cirrhosis. One explanation may include referral bias in other published reports, but the exclusion criteria that applied to preexisting liver disease may also be related. Another possibility could be due to the fact that the mean age of the patient is lower than the one reported from the studies that found higher fibrosis rates since it has been reported that age could be a predictive factor for fibrosis in several studies 
Conclusions
Non alcoholic fatty liver disease seems to be an obeserelated condition with approximately half of asymptomatic morbidly obese patients having histological NASH. The γGT was an independent predictor of the degree of steatosis.
